Recent research identified hundreds of genetic variants influencing brain structure sizes, linking larger volumes to Parkinson’s risk and smaller volumes to ADHD.
Recent statistics from the NHS have highlighted an increase in prescribed medicine for attention deficit hyperactivity disorder (ADHD) over the past year, with a rise of 27.7% in adults compared ...
In May 2024, Knight entered into an agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Ironshore Therapeutics, Inc. (now part of Collegium Pharmaceutical, Inc.; ...